MarketPeel
Insider Trading Intelligence
FN

Felicia F. Norwood

WFC
DIRECTOR · WELLS FARGO & COMPANY/MN · CIK 0001743548
FILING MIX · LIFETIME62%/38%
BUYS
24
SELLS
15
TOTAL VALUE
$21.07M
COMPANIES
2
ACTIVE SINCE
Apr 2022
HOLDINGS NOW
56,690
AVG SELL PX
$488.39
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Felicia F. Norwood, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+66.67%-0.99%+0.52%-1.51%-0.66%
14d9+66.67%+2.00%+3.06%-1.06%-1.66%
30d9+77.78%+1.09%+2.99%-1.91%-2.61%
60d9+0.00%-2.91%+2.03%-4.94%-6.24%
90d9+77.78%-0.45%+6.10%-6.55%-8.27%
180d9+77.78%-8.25%+11.37%-19.62%-19.42%
1y9+77.78%-3.65%+14.00%-17.65%-24.17%
2y9+100.00%+11.75%+46.16%-34.41%-16.49%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
WFC · 17,851.965 shares · as of Apr 28, 2026
04,4638,92613,38917,8522023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 24 buys / 15 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
WFC
WELLS FARGO & COMPANY/MN
PURCHASEGRANT
Stock grant
3,436$81.50$280.0K17,851.965Apr 28, 2026Apr 30, 2026View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP &Chief Health Benefits Ofr
496$284.03$140.9K38,838Mar 3, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
5,95136,469Mar 2, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
23,51223,512Mar 2, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP &Chief Health Benefits Ofr
1,421$294.07$417.9K30,518Mar 2, 2026Mar 4, 2026View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
2,86539,334Mar 2, 2026Mar 4, 2026View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASEGRANT
Stock grant
3,728$71.10$265.1K14,108.472Apr 29, 2025May 1, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
11,54911,549Mar 3, 2025Mar 5, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
3,03527,726Mar 3, 2025Mar 5, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
4,21331,939Mar 3, 2025Mar 5, 2025View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President,Gov Health Ben
2,613$395.50$1.03M24,691Mar 3, 2025Mar 5, 2025View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASEGRANT
Stock grant
4,046$59.32$240.0K10,106.188Apr 30, 2024May 2, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President,Gov Health Ben
3,434$532.68$1.83M27,304Apr 24, 2024Apr 25, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASE
EVP & President,Gov Health Ben
2,043$238.27$486.8K33,503Apr 24, 2024Apr 25, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President,Gov Health Ben
2,765$532.14$1.47M30,738Apr 24, 2024Apr 25, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President,Gov Health Ben
2,0430Apr 24, 2024Apr 25, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President,Gov Health Ben
100$534.74$53.5K31,460Apr 23, 2024Apr 25, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President,Gov Health Ben
5,4732,043Apr 23, 2024Apr 25, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President,Gov Health Ben
14,011$533.73$7.48M31,560Apr 23, 2024Apr 25, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASE
EVP & President,Gov Health Ben
5,473$238.27$1.30M45,571Apr 23, 2024Apr 25, 2024View →
WFC
WELLS FARGO & COMPANY/MN
SALE
118$25.00$3.0K0Mar 15, 2024Mar 19, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
2,40530,946Mar 1, 2024Mar 5, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
9,15240,098Mar 1, 2024Mar 5, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
9,2809,280Mar 1, 2024Mar 5, 2024View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President,Gov Health Ben
4,902$499.11$2.45M28,541Mar 1, 2024Mar 5, 2024View →
WFC
WELLS FARGO & COMPANY/MN
SALE
498$25.00$12.4K0Sep 15, 2023Sep 19, 2023View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASEGRANT
Stock grant
5,919$40.55$240.0K5,919Apr 25, 2023Apr 27, 2023View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASE
77$18.85$1.5K228Mar 16, 2023Apr 27, 2023View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President, GBD
4,754$468.78$2.23M33,443Mar 2, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
9,71638,197Mar 1, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
8,8128,812Mar 1, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
2,29228,481Mar 1, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President, GBD
495$469.03$232.2K26,189Mar 1, 2023Mar 3, 2023View →
ELV
ELEVANCE HEALTH, INC.
SALE
EVP & President, GBD
1,754$512.97$899.7K26,684Dec 30, 2022Jan 4, 2023View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASE
6$18.00$108151Oct 18, 2022Apr 27, 2023View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASE
5$17.84$89152Oct 18, 2022Apr 27, 2023View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASE
1$1,276.63$1.3K11Aug 1, 2022Apr 27, 2023View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASE
9$18.93$170247Aug 1, 2022Apr 27, 2023View →
WFC
WELLS FARGO & COMPANY/MN
PURCHASEGRANT
Stock grant
5,3845,384Apr 26, 2022Apr 28, 2022View →
Other insiders · WFC
Loading peer insiders…
About this filer
CIK 0001743548
ROLE
Director
PRIMARY
WFC
COMPANIES
2
ACTIVE SINCE
Apr 2022
MARKETPEEL · /INSIDER/0001743548DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback